2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL BROMIDE CAS NO.81058-27-7
| inoa | 2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL BROMIDE | ||
| CAS NO. | 81058-27-7 | ||
| ʻĀpana Molekala | C26H43BrO9 | Kaumaha Molecular | 579.53 |
| MDL No. | MFCD08275217 | EINECS | 686-241-8 |
| MP | 147-148°C | BP | 530.5±50.0 °C(Wānana ʻia) |
| ʻO ka mānoanoa | 1.22±0.1 g/cm3(Wānana ʻia) | Hōʻike Hōʻike | NA |
| FP | NA | Kūlana mālama | Ka lewa ʻole, 2-8°C |
| Ka nana aku | Paʻa keʻokeʻo i ke keʻokeʻo | ||
| Maemae | 98% | ||
| Palapala noi | Canagliflozin intermediates, hiki ke hoʻohana ʻia e hoʻomākaukau i ka canagliflozin.ʻO Canagliflozin ka lāʻau lapaʻau SGLT2 mua i ʻāpono ʻia e FDA, hiki ke hoʻohaʻahaʻa i ke kō koko ma ka wāwahi ʻana i ka glucose a hoʻokuʻu ʻia ma o nā puʻupaʻa, a hoʻohana ʻia e mālama i ka maʻi diabetes type 2 i nā pākeke. | ||
| Hiki ke hoolako | 2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL BROMIDE CAS NO.81058-27-7 ʻo kā mākou huahana hana maʻamau, inā makemake ʻoe i kahi laʻana liʻiliʻi a i ʻole ka ukana nui ʻoi aku ma mua o tonnage, kā mākou hui. hiki ke hoolako ia mea ma ke ano | ||
| Inā makemake ʻoe i ka 2,3,4,6-TETRA-O-PIVALOYL-ALPHA-D-GLUCOPYRANOSYL BROMIDE CAS NO.81058-27-7, e ʻoluʻolu e kelepona mai iā mākou, a e hāʻawi mākou iā ʻoe i nā huahana maikaʻi loa. kumukūʻai kūpono a me ka lawelawe maikaʻi loa, e manaʻo ana i kā mākou hui. | |
| | |
| Kelepona No. | +86 139 6251 3054 +86 136 2174 3828 |
ʻO nā huahana i heluʻia e ka hui e pili ana i nā patents, kahi wale nō no ka noiʻi a me ka hoʻomohalaʻana aʻaʻole no ke kūʻai aku;e kūʻai ʻia aku nā huahana i hoʻopaʻa ʻia e like me nā kānāwai Kina a me nā kānāwai o ka ʻāina i kūʻai ʻia ai lākou, a ʻaʻole kūpono nā huahana a pau no ka hoʻohana kanaka.Inā kūʻai ʻia, e lilo lākou i ʻāina hōʻino patent, na ka mea kūʻai aku e lawe i nā pilikia pili.
E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou
![2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS NO.898566-17-1](http://cdn.globalso.com/shlzpharma/898566-17-1.jpeg)
